Airsonett AB

Airsonett AB is a Swedish research-based medical technology company which, with its unique technology, leads the way in the development of non-pharmaceutical treatment for allergic asthma.

The company’s main product is a non-pharmaceutical asthma treatment called Airsonett. Airsonett AB has a comprehensive patent portfolio and invests heavily in clinical research and product development. With strong owners, including SEB Venture Capital, Industrifonden and Magnus Lundberg, Airsonett is also investing in international growth.

Kategorier: Medtech

Gå till Airsonett ABs hemsida

Airsonett AB i Biotechgate

I Biotechgate hittar du detaljerad information om Airsonnet AB, samt information om fler än 2000 andra bolag verksamma inom life science i Sverige.

Gå till Airsonnet AB i Biotechgate

Sök i Biotechgate